ScholarIQanswers from OpenAlex

Extracellular microvesicles and invadopodia mediate non-overlapping modes of tumor cell invasion

PaperCitations, authors & open-access status

Extracellular microvesicles and invadopodia mediate non-overlapping modes of tumor cell invasion is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Extracellular microvesicles and invadopodia mediate non-overlapping modes of tumor cell invasion have?

ScholarIQcitation count

Extracellular microvesicles and invadopodia mediate non-overlapping modes of tumor cell invasion has 162 citations in the OpenAlex counts ScholarIQ stores.

When was Extracellular microvesicles and invadopodia mediate non-overlapping modes of tumor cell invasion published?

ScholarIQyear

Extracellular microvesicles and invadopodia mediate non-overlapping modes of tumor cell invasion has 2015 year in the ScholarIQ index.

What is the open-access status of Extracellular microvesicles and invadopodia mediate non-overlapping modes of tumor cell invasion?

ScholarIQoa status

Extracellular microvesicles and invadopodia mediate non-overlapping modes of tumor cell invasion has gold oa status in the ScholarIQ index.

What is the DOI of Extracellular microvesicles and invadopodia mediate non-overlapping modes of tumor cell invasion?

ScholarIQdoi

The DOI for Extracellular microvesicles and invadopodia mediate non-overlapping modes of tumor cell invasion is on the source record.

What is the PMID of Extracellular microvesicles and invadopodia mediate non-overlapping modes of tumor cell invasion?

ScholarIQpmid

The PMID for Extracellular microvesicles and invadopodia mediate non-overlapping modes of tumor cell invasion is on the source record.

What is the OpenAlex record for Extracellular microvesicles and invadopodia mediate non-overlapping modes of tumor cell invasion?

ScholarIQopenalex

The OpenAlex for Extracellular microvesicles and invadopodia mediate non-overlapping modes of tumor cell invasion is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial